Explore. Illuminate. Deliver.™

Welcome to the enlightening world of iScience Interventional™. We are leading the discovery and development of the product platforms used in Interventional Ophthalmology—a groundbreaking solution for sight-threatening ocular conditions. Through our interventional systems, utilizing advanced imaging and catheter technologies, interventional ophthalmologists can deliver precise, site-specific therapies for the eye.

One site-specific therapy is iCath™ Canaloplasty, the first and only microcatheter-based procedure that safely reduces intraocular pressure (IOP) and dependence on medications in primary open-angle glaucoma patients.

August, 2008 - Canaloplasty Microcatheter FDA Approval

March, 2008 - Canaloplasty clinical study in JCRS.

How to bill for Interventional Glaucoma surgery.